Results 81 to 90 of about 2,327,584 (298)

Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer Patients With Different Metastatic Sites: A Systematic Review and Meta-Analysis

open access: yesFrontiers in Oncology, 2020
Background: Organ-specific response patterns reported in previous studies indicate different response toward immune checkpoint inhibitors (ICIs) in non-small-cell lung cancer (NSCLC) patients with different metastatic sites.
Kaili Yang   +4 more
doaj   +1 more source

Brain metastases from renal cell carcinoma

open access: yes, 2015
Brain metastasis is a major cause of morbidity and mortality in renal cancer patients. Treatment of metastatic renal cancer is difficult because most of RCCs are resistant to several therapeutic strategies: main studies support surgery as a therapeutic ...
FRATI, ALESSANDRO   +3 more
core  

Autonomous Navigation of Pollen‐Inspired Magnetic Microrobots for Biomedical Applications

open access: yesAdvanced Robotics Research, EarlyView.
A sunflower pollen‐inspired magnetic microrobot enables controlled rolling navigation in vessel‐like environments. Its open geometry reduces hydrodynamic drag, while vision‐based closed‐loop control, shortest‐path planning, and reinforcement learning support target‐reaching and maze navigation with microrobot‐scale accuracy, highlighting a route toward
Ali Anil Demircali   +6 more
wiley   +1 more source

Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study

open access: yesBMC Cancer, 2019
Background Non-small cell lung cancer (NSCLC) patients harboring epidermal growth factor receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine kinase inhibitors (TKIs) has shown the effectiveness; however, knowledge of ...
Yung-Hsuan Chen   +4 more
doaj   +1 more source

Cell‐Based Biohybrid Micro/Nanorobots for Biotherapy

open access: yesAdvanced Robotics Research, EarlyView.
This review systematically evaluates cell‐based biohybrid micro/nanorobots (CB‐BMRs), highlighting their cell selection criteria, fabrication strategies, and diverse actuation modes. Furthermore, it surveys the promising therapeutic applications of CB‐BMRs in targeted cancer, thrombosis, and inflammation treatments, while comprehensively discussing ...
Lin Wang   +11 more
wiley   +1 more source

Emerging role of brain metastases in the prognosis of breast cancer patients

open access: yes, 2011
Amanda Hambrecht1,2, Rahul Jandial2, Josh Neman21Department of Biology, University of Southern California; 2Department of Neurosurgery, Beckman Research Institute, City of Hope National Cancer Center, CA, USAAbstract: Cancer starts with one rogue cell ...
Neman J, Jandial R, Hambrecht A
core  

Distribution of clinical factors by presence of brain metastases at baseline or development of subsequent brain metastases after baseline.

open access: yes, 2018
Distribution of clinical factors by presence of brain metastases at baseline or development of subsequent brain metastases after baseline.
Melissa L. Johnson (843156)   +12 more
core   +1 more source

Loss of E3 Ubiquitin Ligase RINES via CpG Methylation Relieves Suppression of STAT3 and MYC, Facilitating Multiple Tumorigeneses

open access: yesAdvanced Science, EarlyView.
Dysregulated protein modifications drive tumorigenesis. RINES, an E3 ubiquitin ligase, represses tumor cell proliferation and metastasis by facilitating RING domain‐dependent, ubiquitin–proteasome‐mediated degradation of STAT3 and MYC, which consequently restrains cancer stemness and oncogenic progression.
Lili Li   +8 more
wiley   +1 more source

Platinum Sensitivity as an Independent Prognostic Factor in Patients with Brain Metastases from Ovarian Carcinoma

open access: yesMiddle East Journal of Cancer, 2011
Background: The brain is a rare site of metastases from ovarian cancer. Limited data are available on prognostic factors, standard treatment, and survival.
John Windara Green   +5 more
doaj  

Targeting B7-H3 in patients with metastatic triple-negative breast cancer and brain metastases: an opportunity to “revive” immunotherapy as a treatment strategy?

open access: yesJournal for ImmunoTherapy of Cancer
Approximately one-third of patients with metastatic triple-negative breast cancer (TNBC) develop brain metastases during their lifetime. Notably, up to 90% of TNBC brain metastases express B7-H3, a molecule that contributes to an immunosuppressive ...
Jane Bayani   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy